Biopharmaceutical Engineering with a Year in Industry

Course Overview

The MSc Biopharmaceutical Engineering with a Year in Industry at Queen's University Belfast is a postgraduate programme designed for postgraduate students passionate about driving digital innovation. this Russell Group university offers a research-led approach to learning, with a 2-year full-time and part-time structure. Biopharmaceutical products are highly important in today’s global healthcare systems in treating illnesses and disease. The industry in the British Isles has seen significant investment, particularly in the Republic of Ireland (RoI) where there has been capital investment of approximately £7.97 billion in new facilities, mostly in the last 10 years. The global market for biopharmaceuticals was valued at £149 billion in 2017, and is projected to reach £419 billion by 2025, growing at an annual rate of 13.8% from 2018 to 2025. International tuition fees are £7,700 per year, home/UK fees are £6,500 per year, and a minimum IELTS score of 6.5 is required for admission. Graduates from this programme benefit from strong career prospects, with 96% student satisfaction rating, a 95% continuation rate, and 75% of graduates in employment or further study.

What You'll Learn

Tuition Fees & Funding

Fees shown are for current entry. Fees may increase annually in line with inflation.

Graduate Outcomes

Based on official HESA Graduate Outcomes survey data

Frequently Asked Questions